Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Intravenous Dexmedetomidine Infusion Standard Anesthesia

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 4 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07073846Phase 4Recruiting

Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.

NCT04611763Phase 1Completed

Effect of Preemptive Analgesia With Flurbiprofen Axetil on Perioperative Sleep Quality and Postoperative Pain in Patients Undergoing Laparoscopic Gynecological Surgery.

Showing all 2 trials

Research Network

Common Treatments

  • Intravenous Dexmedetomidine Infusion Standard Anesthesia1
  • Intravenous Lidocaine Infusion Standard Anesthesia1
  • Flurbiprofen Axetil Preoperatively1
  • Flurbiprofen Axetil Postoperatively1
  • Lidocaine Dexmedetomidine Combination Lidex Standard Anesthesia1

Active Sponsors

  • Beijing Friendship Hospital1
  • Instituto Mexicano del Seguro Social1

Top Investigators

Related Conditions

  • Postoperative Pain2
  • Morbid Obesity Requiring Bariatric Surgery1
  • Postoperative Adjuvant Treatment1
  • Postoperative Inflammatory Response1
  • Postoperative Analgesia1

Activity Timeline